TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
SCYX

Scynexis Inc

Healthcare · Drug Manufacturers - Specialty & Generic

5.00$ -1.8% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Scynexis Inc (SCYX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 75 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SCYX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
61 60 57 52 50 46 65 58 52 53 45 41 34 57 42 45 37 103 100 121 110 120 112 136 112 88 70 155 149 128 118 108 99 91 68 61 51 59 78 75
54 59 56 51 49 45 64 57 50 51 40 36 29 52 37 41 32 98 95 116 104 109 102 126 104 79 60 146 129 102 102 95 80 72 52 56 49 40 63 56
30 36 20 7.5 8.7 11 27 6.8 16 11 13 19 12 42 20 34 29 93 92 113 100 104 95 119 69 46 27 58 44 34 36 26 29 16 6.9 11 15 21 37 10
52 59 55 49 48 44 64 55 49 44 39 35 28 48 35 38 29 93 92 113 100 104 95 119 96 74 55 86 88 74 81 73 69 59 41 45 38 40 59 54
1.0 0.2 0.1 0.3 0.3 0.3 0.3 0.2 0.2 6.7 6.7 – – – – – – 2.9 1.0 2.7 0.0 0.9 1.6 2.2 2.5 2.1 2.1 47 24 22 19 20 9.7 10 9.7 10 10 – – –
0.8 0.5 0.0 1.2 0.7 0.7 0.3 1.1 0.5 0.5 – – – – – – – 1.9 2.0 0.1 0.6 0.5 1.1 0.6 0.8 0.9 1.1 10 13 0.0 – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.5 0.5 0.5 0.4 0.4 0.4 0.4 0.3 3.3 0.3 6.2 2.9 0.1 2.8 2.7 2.6 – – 2.5 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – 0.4 0.6 1.1 1.1 1.0 0.9 0.8 0.4 0.3 0.2 0.1 – – – – – – – – – – –
28 25 23 20 22 24 29 31 24 22 34 31 28 44 35 39 27 80 74 89 72 79 73 90 95 85 100 62 57 55 44 47 41 36 17 16 15 9.7 36 8.0
4.0 3.7 3.4 4.7 6.7 10 11 13 11 5.9 4.6 7.2 8.1 11 7.1 7.3 8.3 26 25 20 13 14 13 16 14 18 46 16 17 16 27 25 26 24 9.0 11 8.5 5.7 16 5.8
– 14 14 1.3 2.8 4.3 3.6 5.5 7.3 – 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.7 0.3 0.3 35 0.3 0.3 0.3 13 13 14 14 0.4 0.4 0.5 0.5 0.5 0.5
2.5 2.2 2.0 1.7 1.8 3.8 3.3 2.6 2.0 3.7 2.3 3.8 5.8 7.2 5.2 4.9 5.3 4.6 6.5 5.9 7.5 7.8 8.1 10.0 7.4 5.9 5.9 3.4 3.5 7.1 8.9 5.4 5.0 4.6 4.3 6.2 3.5 2.2 5.6 3.3
14 14 14 13 12 10 11 9.4 7.6 15 18 15 13 12 11 18 13 17 12 40 29 29 45 34 34 45 11 12 12 12 – – – – – – – – – –
33 35 34 32 27 21 37 27 28 31 11 10 6.1 13 6.5 6.3 9.6 23 26 32 38 41 39 45 17 3.2 -30 93 92 73 74 60 59 55 51 44 36 49 41 67
-177 -180 -185 -189 -198 -205 -209 -220 -220 -218 -241 -249 -257 -271 -278 -285 -284 -327 -331 -330 -330 -359 -365 -378 -408 -422 -456 -334 -336 -355 -355 -369 -372 -377 -382 -389 -397 -385 -406 -399
2.3 2.5 2.6 2.6 2.7 2.9 3.4 0.6 0.6 0.6 0.6 0.7 0.8 0.8 1.2 0.1 1.7 1.4 3.3 3.3 3.5 3.5 4.1 5.4 5.9 4.1 6.0 6.2 6.0 4.7 6.1 6.1 6.1 4.7 6.2 6.2 6.2 5.4 6.4 12

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?